These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 28056754)

  • 21. Metagenomic data-mining reveals enrichment of trimethylamine-N-oxide synthesis in gut microbiome in atrial fibrillation patients.
    Zuo K; Liu X; Wang P; Jiao J; Han C; Liu Z; Yin X; Li J; Yang X
    BMC Genomics; 2020 Jul; 21(1):526. PubMed ID: 32731896
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The emerging role of gut microbial metabolism on cardiovascular disease.
    Kasahara K; Rey FE
    Curr Opin Microbiol; 2019 Aug; 50():64-70. PubMed ID: 31693963
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intestinal Microbiota Metabolism and Atherosclerosis.
    Liu TX; Niu HT; Zhang SY
    Chin Med J (Engl); 2015 Oct; 128(20):2805-11. PubMed ID: 26481750
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Multi-omic Association Study of Trimethylamine N-Oxide.
    Manor O; Zubair N; Conomos MP; Xu X; Rohwer JE; Krafft CE; Lovejoy JC; Magis AT
    Cell Rep; 2018 Jul; 24(4):935-946. PubMed ID: 30044989
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interaction between gut microbiome and cardiovascular disease.
    Peng J; Xiao X; Hu M; Zhang X
    Life Sci; 2018 Dec; 214():153-157. PubMed ID: 30385177
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Archaea, specific genetic traits, and development of improved bacterial live biotherapeutic products: another face of next-generation probiotics.
    Fadhlaoui K; Arnal ME; Martineau M; Camponova P; Ollivier B; O'Toole PW; Brugère JF
    Appl Microbiol Biotechnol; 2020 Jun; 104(11):4705-4716. PubMed ID: 32281023
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human microbiome as therapeutic intervention target to reduce cardiovascular disease risk.
    Koopen AM; Groen AK; Nieuwdorp M
    Curr Opin Lipidol; 2016 Dec; 27(6):615-622. PubMed ID: 27676197
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microbiome Medicine: Microbiota in Development and Management of Cardiovascular Diseases.
    Garg Y; Kanwar N; Chopra S; Tambuwala MM; Dodiya H; Bhatia A; Kanwal A
    Endocr Metab Immune Disord Drug Targets; 2022; 22(14):1344-1356. PubMed ID: 35761484
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Relationship between Choline Bioavailability from Diet, Intestinal Microbiota Composition, and Its Modulation of Human Diseases.
    Arias N; Arboleya S; Allison J; Kaliszewska A; Higarza SG; Gueimonde M; Arias JL
    Nutrients; 2020 Aug; 12(8):. PubMed ID: 32764281
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Archaebiotics: proposed therapeutic use of archaea to prevent trimethylaminuria and cardiovascular disease.
    Brugère JF; Borrel G; Gaci N; Tottey W; O'Toole PW; Malpuech-Brugère C
    Gut Microbes; 2014; 5(1):5-10. PubMed ID: 24247281
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of diet on hypertensive pathology: is there a link via gut microbiota-driven immunometabolism?
    Jama HA; Beale A; Shihata WA; Marques FZ
    Cardiovasc Res; 2019 Jul; 115(9):1435-1447. PubMed ID: 30951169
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional food addressing heart health: do we have to target the gut microbiota?
    Ryan PM; Ross RP; Fitzgerald GF; Caplice NM; Stanton C
    Curr Opin Clin Nutr Metab Care; 2015 Nov; 18(6):566-71. PubMed ID: 26406391
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Understanding connections and roles of gut microbiome in cardiovascular diseases.
    Rajendiran E; Ramadass B; Ramprasath V
    Can J Microbiol; 2021 Feb; 67(2):101-111. PubMed ID: 33079568
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exploring the Microbiome in Heart Failure.
    Kitai T; Kirsop J; Tang WH
    Curr Heart Fail Rep; 2016 Apr; 13(2):103-9. PubMed ID: 26886380
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of Gut Microbiota and Their Metabolites on Atherosclerosis, Hypertension and Human Blood Platelet Function: A Review.
    Duttaroy AK
    Nutrients; 2021 Jan; 13(1):. PubMed ID: 33401598
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The gut microbiota and its interactions with cardiovascular disease.
    Xu H; Wang X; Feng W; Liu Q; Zhou S; Liu Q; Cai L
    Microb Biotechnol; 2020 May; 13(3):637-656. PubMed ID: 31984651
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trimethylamine N-Oxide, the Microbiome, and Heart and Kidney Disease.
    Zeisel SH; Warrier M
    Annu Rev Nutr; 2017 Aug; 37():157-181. PubMed ID: 28715991
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microbiome, trimethylamine N-oxide, and cardiometabolic disease.
    Tang WH; Hazen SL
    Transl Res; 2017 Jan; 179():108-115. PubMed ID: 27490453
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metaorganismal nutrient metabolism as a basis of cardiovascular disease.
    Brown JM; Hazen SL
    Curr Opin Lipidol; 2014 Feb; 25(1):48-53. PubMed ID: 24362355
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trimethylamine N-Oxide Generated by the Gut Microbiota: Potential Atherosclerosis Treatment Strategies.
    Zhu B; Ren H; Xie F; An Y; Wang Y; Tan Y
    Curr Pharm Des; 2022; 28(35):2914-2919. PubMed ID: 36121073
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.